The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

Saudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.

CONTACT DERMATITIS, published by WILEY, is a leading international journal focused on the vital field of dermatology, particularly examining the diagnosis, treatment, and management of contact dermatitis and related skin conditions. With origins dating back to 1975 and a planned convergence period extending to 2024, this esteemed journal serves as a crucial resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge in dermatological practices. In the latest rankings, it has achieved a commendable Q2 classification in Dermatology and Q3 classification in Immunology and Allergy for 2023, underscoring its significance within these dynamic fields. Moreover, it holds a notable ranking of #29/142 in Medicine & Dermatology and #130/233 in Medicine & Immunology and Allergy according to Scopus metrics, placing it in the top tier of scholarly publications. While the journal operates on a subscription basis, its comprehensive reviews, original articles, and insightful research findings are invaluable for pushing the boundaries of current dermatological and immunological knowledge. By fostering a deeper understanding of the complexities of skin reactions and their implications, CONTACT DERMATITIS plays a vital role in connecting research with clinical practice, making it an essential read for anyone engaged in the field.

OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.

BMJ Open Ophthalmology is an esteemed, open-access journal dedicated to the field of ophthalmology, published by the renowned BMJ Publishing Group. Established in 2016, this journal has quickly made its mark within the ophthalmology community, achieving a respectable Q2 ranking in the 2023 category quartiles. It is indexed in Scopus, boasting a commendable ranking of **#52** out of **137** in the medicine discipline of ophthalmology, placing it in the **62nd percentile**. This global platform is committed to disseminating high-quality research, clinical studies, and innovative practices that propel the understanding and treatment of eye diseases. With its open access model, BMJ Open Ophthalmology ensures that vital research is readily available to health professionals, researchers, and students, fostering collaboration and advancing knowledge within the field. The journal is based in London, United Kingdom, and continues to welcome submissions that explore the latest advancements in ophthalmic science, contributing to enhanced patient care and outcomes.

CORNEA is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the rapidly advancing field of ophthalmology with a particular emphasis on corneal research and diseases. With an impact factor categorized in the prestigious Q1 quartile for its discipline, CORNEA has established itself as a leading platform for the dissemination of both fundamental and clinical studies since its inception in 1982. The journal is ranked 25th out of 137 in the Scopus Medicine-Ophthalmology category, placing it in the 82nd percentile among its peers, which underscores its vital role in influencing ocular research and clinical practices. While the journal is not currently open access, it provides valuable insights and updates for professionals, researchers, and students working to advance knowledge in corneal health, contributing significantly to the ongoing dialogue in the ophthalmological community. With a commitment to excellence, CORNEA continues to publish high-quality research and reviews in its pursuit to improve ocular outcomes and patient care.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

Clinical Ophthalmology is a leading Open Access journal published by Dove Medical Press Ltd, dedicated to advancing the field of ophthalmology through peer-reviewed research and clinical studies. With a strong impact factor and ranked in the Q1 category of ophthalmology as of 2023, this journal is recognized for its significant contribution to the body of knowledge pertaining to eye health, vision science, and clinical practice. Its Scopus ranking places it within the top 30% of journals in the field, reflecting its influence and relevance in both academic and clinical landscapes. Since its inception in 2007, Clinical Ophthalmology has established a reputation for fostering high-quality research, providing a platform for researchers, professionals, and students to share their findings and insights. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, supporting innovation and collaboration in the pursuit of better patient outcomes worldwide. For those engaged in ophthalmological research and clinical practice, Clinical Ophthalmology serves as an invaluable resource and a hub for the latest developments in the field.

The Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.

Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.